Skip to main content
Log in

Synthesis and Antimycobacterial Activity of 5-(Hetarylmethylidene)-2,4,6-Pyrimidine- 2,4,6(1H,3H,5H )-Triones And 5-(2-Chloropropylidene)- 2,4,6-Pyrimidine-2,4,6(1H,3H,5H )-Triones

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Series of 5-(hetarylmethylidene)-2,4,6-pyrimidine-2,4,6(1H,3H,5H)-triones and 5-(2-chloropropylidene)- 2,4,6-pyrimidine-2,4,6(1H,3H,5H)-triones were synthesized and tested for antimycobacterial activity against M. lufu and acute toxicity. The 5-(hetarylmethylidene)-2,4,6-pyrimidine-2,4,6(1H,3H,5H)-triones and 5-(2-chloropropylidene)-2,4,6-pyrimidine-2,4,6(1H,3H,5H)-triones were shown to possess low toxicity and antimycobacterial activity of various strengths as compared to dapsone and could be considered promising compounds for further discovery of antimycobacterial drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chemotherapy of Leprosy for Control Programmes, WHO Tech. Rep. Ser. 675, Geneva (1982).

  2. S. K. Noordeen, Clin. Dermatol., 34, 32 – 36 (2016).

    Article  PubMed  Google Scholar 

  3. A. A. Kubanov, A. E. Karamova, A. A. Vorontsova, and P. A. Kalinina, Vestn. Dermatol. Venerol., 4, 12 – 19 (2016).

    Google Scholar 

  4. H. K. Kar and R. Gupta, Clin. Dermatol., 33, 55 – 56 (2015).

    Article  PubMed  Google Scholar 

  5. V. Z. Naumov, E. A. Zadneprovskaya, and A. A. Yushchenko, Vestn. Dermatol. Venerol., 6, 21 – 23 (2006).

    Google Scholar 

  6. A. R. Gimadieva, Yu. N. Chernyshenko, A. G. Mustafin, and I. B. Abdrakhmanov, Bashk. Khim. Zh., 14(3), 5 – 21 (2007).

    CAS  Google Scholar 

  7. A. G. Tyrkov, N. G. Urlyapova, and A. D. Daudova, Khim.- farm. Zh., 40(7), 30 – 31 (2006); Pharm. Chem. J., 40(7), 377 – 379 (2006).

  8. S. A. Luzhnova, A. G. Tyrkov, N. M. Gabitova, and E. A. Yurgaeva, Khim.-farm. Zh., 49(12), 12 – 14 (2015); Pharm. Chem. J., 49(12), 810 – 812 (2016).

  9. E. A. Yurgaeva and A. G. Tyrkov, Zh. Org. Khim., 52(2), 305 – 307 (2016); Russ. J. Org. Chem., 52(2), 289 – 291 (2016).

  10. E. Pretsch, P. Buhlmann, and C. Affolter, Structure Determination of Organic Compounds, Springer, Berlin, New York (2000) [Russian translation, Binom, Laboratoriya Znanii, Mir, Moscow (2006), pp. 393 – 395].

  11. A. A. Potekhin, Properties of Organic Compounds [in Russian], Khimiya, Leningrad (1984), p. 296.

  12. J. G. Kirchner, Techniques of Chemistry, Vol. 14: Thin-Layer Chromatography, 2nd Ed., Wiley-Interscience, New York (1978), 1137 pp [Russian translation, Vol. 1, Mir, Moscow (1981), pp. 129, 218].

  13. F. Portaels, Ann. Soc. Belge Med. Trop., 60, 381 – 386 (1980).

    CAS  Google Scholar 

  14. J. K. Seydel and E. C. Wempe, Int. J. Lepr., 50(1), 20 – 30 (1982).

    CAS  Google Scholar 

  15. O. A. Irtuganova and N. G. Urlyapova, Aktual. Vopr. Lepr. (Astrakhan’), 148 – 150 (1984).

  16. F. Portaels, XIIth International Leprosy Congress: Abstracts, New Delhi, IV, 220 A (1984).

  17. S. M. Navashin and I. P. Fomina, Handbook of Antibiotics [in Russian], Meditsina, Moscow (1974), p. 54.

  18. Handbook for Preclinical Drug Trials [in Russian], Grif i K, Moscow (2012), p. 944.

  19. S. Glantz, Primer of Biostatistics, 4th Ed., McGraw-Hill Inc., New York (1997), 473 pp [Russian translation, Praktika, Moscow (1999), p. 459].

  20. M. D. Mashkovskii, Drugs [in Russian], Novaya Volna, Moscow (2006), p. 873.

  21. A. G. Pashinyan, Med. Sovet, 3, 4, 46 – 47 (2011).

  22. N. Coen, S. Duraffour, D. Topalis, R. Snoeck, and G. Andrei, Antimicrob. Agents Chemother., 58(12), 7312 – 7323 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The work was performed in the framework of a State Task for the Ministry of Health of Russia, Project No. 056-00074-19-00 and was financially supported by the Ministry of Education and Science of the RF, Grant No. 4.9288.2017BCh.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. G. Tyrkov.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 54, No. 2, pp. 32 – 35, February, 2020.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yushin, M.Y., Tyrkov, A.G., Saroyants, L.V. et al. Synthesis and Antimycobacterial Activity of 5-(Hetarylmethylidene)-2,4,6-Pyrimidine- 2,4,6(1H,3H,5H )-Triones And 5-(2-Chloropropylidene)- 2,4,6-Pyrimidine-2,4,6(1H,3H,5H )-Triones. Pharm Chem J 54, 134–137 (2020). https://doi.org/10.1007/s11094-020-02169-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-020-02169-z

Keywords

Navigation